Biotech Growth Investors & VC Firms

708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AC ACT Venture Capital JFJODRAO11 people	88🔒	Dublin	IE	Seed–Growth	$1.1M – $16.2M	+ Add to CRM
CA Cathay Capital PSJDLLXC11 people · Leads rounds	88🔒	Stamford	US	Growth	—	+ Add to CRM
CR Crossbeam Venture Partners AHSJCRRD8 people · Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	$1M – $1.5M	+ Add to CRM
KE Keensight Capital AKSDYYCG4 people · Leads rounds	88🔒	Paris	FR	Growth–Late Stage	$10M – $800M	+ Add to CRM
PR Prime Partners JCLZRLRM4 people	88🔒	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
DN DNA Capital GCPMPBSR15 people · Leads rounds	88🔒	São Paulo	BR	Seed–Late Stage	$100K – $5M	+ Add to CRM
IN Invus BTCTRMSL8 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
SI SIB Innovations- und Beteiligungsgesellschaft CMMGMKMS10 people	88🔒	Dresden	DE	Seed–Growth	$54K – $10.8M	+ Add to CRM
AL Alkemi Growth Capital AGMAAKAB15 people · Leads rounds	88🔒	New Delhi	IN	Pre-Seed–Growth	—	+ Add to CRM
HB HBM Partners FDCLDDSS6 people	88🔒	Zug	CH	Seed–Late Stage	$5M – $50M	+ Add to CRM
BR Brightstone Venture Capital JCPODDDN11 people · Leads rounds	88🔒	Minneapolis	US	Seed–Growth	$250K – $10M	+ Add to CRM
IN INCE Capital PKSZSHBD12 people · Follows rounds	88🔒	Shanghai	CN	Seed–Growth	—	+ Add to CRM
JK JK&B Capital DKADASMS9 people · Leads rounds	88🔒	Chicago	US	Seed–Late Stage	—	+ Add to CRM
AL Ally Bridge Group FYKRSPCS7 people · Leads rounds	88🔒	New York	US	Growth–Late Stage	—	+ Add to CRM
TR Trinity Capital JEKBRKSS16 people	88🔒	Phoenix	US	Growth	—	+ Add to CRM
BO Boehringer Ingelheim Venture Fund SEMHBHMB16 people	88🔒	Ingelheim am Rhein	DE	Seed–Growth	$16.2M	+ Add to CRM
NE New Science Ventures SSTLAAJB7 people · Leads rounds	88🔒	Greenwich	US	Seed–Late Stage	$2M – $8M	+ Add to CRM
EF EFung Capital	88🔒	Shenzhen	CN	Series A–Growth	—	+ Add to CRM
GR Grazia Equity GmbH ARBBJKJK9 people · Leads rounds	88🔒	Stuttgart	DE	Seed–Growth	$540K – $2.7M	+ Add to CRM
H. H.I.G. HealthBridge Partners SMTTMFMM12 people	88🔒	Miami	US	Growth	$5M – $40M	+ Add to CRM
NO NovaCapital CGPMMCCA9 people	88🔒	—	IT	Seed–Late Stage	—	+ Add to CRM
SI Simon Capital JLSGFDNH9 people · Leads rounds	88🔒	Düsseldorf	DE	Seed–Growth	$540K – $10.8M	+ Add to CRM
BI Bios Partners LWAGADJF17 people	88🔒	Fort Worth	US	Seed–Growth	—	+ Add to CRM
NE Neva Sgr. LRAGKSLN8 people · Follows rounds	88🔒	Turin	IT	Series A–Growth	—	+ Add to CRM

ACT Venture Capital

DublinSeed–Growth$1.1M – $16.2M

JFJODRAO11 people

Cathay Capital

StamfordGrowth

PSJDLLXC11 people

Crossbeam Venture Partners

New YorkPre-Seed–Late Stage$1M – $1.5M

AHSJCRRD8 people

Keensight Capital

ParisGrowth–Late Stage$10M – $800M

AKSDYYCG4 people

Prime Partners

TokyoPre-Seed–Growth

JCLZRLRM4 people

DNA Capital

São PauloSeed–Late Stage$100K – $5M

GCPMPBSR15 people

Invus

New YorkSeed–Late Stage

BTCTRMSL8 people

SIB Innovations- und Beteiligungsgesellschaft

DresdenSeed–Growth$54K – $10.8M

CMMGMKMS10 people

Alkemi Growth Capital

New DelhiPre-Seed–Growth

AGMAAKAB15 people

HBM Partners

ZugSeed–Late Stage$5M – $50M

FDCLDDSS6 people

Brightstone Venture Capital

MinneapolisSeed–Growth$250K – $10M

JCPODDDN11 people

INCE Capital

ShanghaiSeed–Growth

PKSZSHBD12 people

JK&B Capital

ChicagoSeed–Late Stage

DKADASMS9 people

Ally Bridge Group

New YorkGrowth–Late Stage

FYKRSPCS7 people

Trinity Capital

PhoenixGrowth

JEKBRKSS16 people

Boehringer Ingelheim Venture Fund

Ingelheim am RheinSeed–Growth$16.2M

SEMHBHMB16 people

New Science Ventures

GreenwichSeed–Late Stage$2M – $8M

SSTLAAJB7 people

EFung Capital

ShenzhenSeries A–Growth

Grazia Equity GmbH

StuttgartSeed–Growth$540K – $2.7M

ARBBJKJK9 people

H.I.G. HealthBridge Partners

MiamiGrowth$5M – $40M

SMTTMFMM12 people

NovaCapital

Seed–Late Stage

CGPMMCCA9 people

Simon Capital

DüsseldorfSeed–Growth$540K – $10.8M

JLSGFDNH9 people

Bios Partners

Fort WorthSeed–Growth

LWAGADJF17 people

Neva Sgr.

TurinSeries A–Growth

LRAGKSLN8 people

Data sourced from public filings and firms' own websites — see our methodology.